Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

HIV

Germline-targeting immunogens guide bnAb development

Nature Immunology volume 25, pages 944–946 (2024)Cite this article

Subjects

Structure-guided protein design enables germline-targeting immunization strategies to generate broadly neutralizing antibodies against MPER, a region of the HIV envelope glycoprotein that is functionally important and highly conserved, but a challenging target for antibody responses.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Immunization with MPER germline-targeting immunogens.

References

  1. Burton, D. R. & Hangartner, L. Annu. Rev. Immunol. 34, 635–659 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Sneller, M. C. et al. Nature 606, 375–381 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Schiffner, T. et al. Nat. Immunol. https://doi.org/10.1038/s41590-024-01833-w (2024).

    Article  PubMed  Google Scholar 

  4. Ray, R. et al. Nat. Immunol. https://doi.org/10.1038/s41590-024-01844-7 (2024).

    Article  PubMed  Google Scholar 

  5. Julien, J.-P. et al. Science 342, 1477–1483 (2013).

    Article  CAS  PubMed  Google Scholar 

  6. Haynes, B. F. et al. Nat. Rev. Immunol. 23, 142–158 (2023).

    Article  CAS  PubMed  Google Scholar 

  7. Huang, J. et al. Nature 491, 406–412 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Jardine, J. G. et al. Science 351, 1458–1463 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Leggat, D. J. et al. Science 378, eadd6502 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute for Immunity, Transplantation and Infection, Stanford University, Stanford, CA, USA

    Tobias V. Lanz

  2. Division of Immunology and Rheumatology, Department of Medicine, Stanford University, Stanford, CA, USA

    Tobias V. Lanz

Authors
  1. Tobias V. Lanz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tobias V. Lanz.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lanz, T.V. Germline-targeting immunogens guide bnAb development. Nat Immunol 25, 944–946 (2024). https://doi.org/10.1038/s41590-024-01852-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41590-024-01852-7

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing